It is worthy to note that PtPT distinctly triggers ERK phosphorylation, although it is not sufficient to fully protect CML cells from DUBs inhibition-mediated apoptosis. Here, PTPN2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.